New combo device aims to keep patients breathing safely during lung scope
NCT ID NCT07063290
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a new device called the COMBO Endoscopy Oropharyngeal Airway in 104 adults undergoing a sedated lung procedure (fiberoptic bronchoscopy). The device combines oxygen delivery, airway support, and breathing monitoring into one tool. The goal was to see if it could reduce episodes of low oxygen (hypoxia) compared to standard care. If successful, it could make these common procedures safer.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
COMBO Endoscopy Oropharyngeal Airway (a device that provides oxygen, monitors breathing, and keeps the airway open)
What this could lead to
If it works, this device could reduce the risk of dangerously low oxygen levels during sedated bronchoscopy, making the procedure safer and more comfortable.
What could go wrong
This is a small, early-phase trial (104 people) testing a device, not a new drug. The device may not work better than standard care, and results may not apply to all patients or longer procedures.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRONCHIECTASIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The First Affliated Hospital, Zhejiang University School Of Medicine
Hangzhou, Zhejiang, 310000, China